SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 149 filers reported holding SERES THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,972 | -81.7% | 29,400 | -63.2% | 0.00% | – |
| Q2 2023 | $382,400 | +70.4% | 79,833 | +101.7% | 0.00% | – |
| Q1 2023 | $224,419 | -10.5% | 39,580 | -11.6% | 0.00% | – |
| Q4 2022 | $250,818 | +5.8% | 44,789 | +34.7% | 0.00% | – |
| Q1 2022 | $237,000 | -91.4% | 33,260 | -89.9% | 0.00% | – |
| Q4 2021 | $2,756,000 | +85.5% | 330,787 | +55.0% | 0.00% | – |
| Q3 2021 | $1,486,000 | -77.4% | 213,454 | -22.5% | 0.00% | -100.0% |
| Q2 2021 | $6,568,000 | +39.6% | 275,410 | +20.5% | 0.00% | 0.0% |
| Q1 2021 | $4,705,000 | +21.4% | 228,522 | +44.5% | 0.00% | 0.0% |
| Q4 2020 | $3,875,000 | -3.9% | 158,135 | +11.0% | 0.00% | -33.3% |
| Q3 2020 | $4,033,000 | +5830.9% | 142,435 | +894.2% | 0.00% | – |
| Q2 2020 | $68,000 | +61.9% | 14,327 | +22.2% | 0.00% | – |
| Q1 2020 | $42,000 | -78.8% | 11,722 | -79.6% | 0.00% | – |
| Q4 2019 | $198,000 | -46.5% | 57,427 | -37.8% | 0.00% | -100.0% |
| Q3 2019 | $370,000 | +0.3% | 92,348 | -19.5% | 0.00% | 0.0% |
| Q2 2019 | $369,000 | – | 114,659 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |